Amiloidosis Cardiaca. Actualización de la Cardiología Nuclear en el diagnóstico y seguimiento.

Q: What is the clinical evidence from this study?

Study design: Review. Population: Cardiac Amyloidosis. Intervention: Molecular imaging (Tc-diphosphonates, Amyloid PET).

A Jiménez Heffernan; N Orta Tomás; V Pubul Nuñez; R Ruano Pérez

doi:10.1016/j.remnie.2026.500322

May 11, 2026

Amiloidosis Cardiaca. Actualización de la Cardiología Nuclear en el diagnóstico y seguimiento.

View Full Paper

Ask AI

Bookmark

Share

Why the study?

Recent advances in molecular imaging and disease-modifying therapies have changed the prognosis and management of patients with cardiac amyloidosis.

Key Points

This article aims to update the current understanding and advancements in nuclear cardiology related to cardiac amyloidosis.
Describes the use of Tc-diphosphonates with SPECT/CT for diagnosing cardiac amyloidosis.
Discusses amyloid PET imaging with pan-amyloid radiopharmaceuticals for quantifying amyloid load.
Reviews the development of disease-modifying therapies like TTR stabilizers and anti-amyloid agents.
SPECT/CT improves diagnostic and prognostic capabilities for cardiac amyloidosis.
Amyloid PET imaging enhances early diagnosis and quantification of amyloid load.
New modifying therapies have positively impacted the prognosis of patients with cardiac amyloidosis.

Structured PICO

P

Population

Patients with Cardiac Amyloidosis (CA)

I

Intervention

Molecular imaging (Tc-diphosphonates SPECT/CT, Amyloid PET) and disease-modifying therapies

Implication

Advances in molecular imaging, such as SPECT/CT and PET, improve early diagnosis, quantification, and prognostic evaluation of cardiac amyloidosis, complementing new disease-modifying therapies.

Discussion

No takes yet. Share an insight, caveat, or question.

Cite This Study

Heffernan et al. (2026) conducted a review in Cardiac Amyloidosis. Molecular imaging (Tc-diphosphonates, Amyloid PET) was evaluated.

synapsesocial.com/papers/6a06b95be7dec685947abf77 https://doi.org/10.1016/j.remnie.2026.500322

Topics

Cardiac amyloidosis

View Full Paper

Ask AI

Bookmark

Share

Amiloidosis Cardiaca. Actualización de la Cardiología Nuclear en el diagnóstico y seguimiento.

Key Points

Structured PICO

Implication

Discussion

Cite This Study

Topics

Amiloidosis Cardiaca. Actualización de la Cardiología Nuclear en el diagnóstico y seguimiento.

Key Points

Structured PICO

Implication

Discussion

Cite This Study

Keep reading

Topics

Keep reading